U.S. markets open in 4 hours 46 minutes
  • S&P Futures

    +40.25 (+1.06%)
  • Dow Futures

    +301.00 (+0.97%)
  • Nasdaq Futures

    +169.00 (+1.31%)
  • Russell 2000 Futures

    +46.90 (+2.13%)
  • Crude Oil

    +0.96 (+1.56%)
  • Gold

    +17.00 (+0.98%)
  • Silver

    +0.43 (+1.65%)

    -0.0048 (-0.40%)
  • 10-Yr Bond

    0.0000 (0.00%)
  • Vix

    -3.64 (-12.60%)

    +0.0023 (+0.17%)

    +0.2080 (+0.20%)

    +2,295.23 (+5.10%)
  • CMC Crypto 200

    +16.00 (+1.71%)
  • FTSE 100

    +115.50 (+1.78%)
  • Nikkei 225

    +697.49 (+2.41%)

If You Had Bought Syneos Health (NASDAQ:SYNH) Shares Five Years Ago You'd Have Earned25% Returns

  • Oops!
    Something went wrong.
    Please try again later.
Simply Wall St
·3 min read
  • Oops!
    Something went wrong.
    Please try again later.

If you buy and hold a stock for many years, you'd hope to be making a profit. Furthermore, you'd generally like to see the share price rise faster than the market But Syneos Health, Inc. (NASDAQ:SYNH) has fallen short of that second goal, with a share price rise of 25% over five years, which is below the market return. Looking at the last year alone, the stock is up 10.0%.

Check out our latest analysis for Syneos Health

There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.

During five years of share price growth, Syneos Health achieved compound earnings per share (EPS) growth of 67% per year. The EPS growth is more impressive than the yearly share price gain of 4.6% over the same period. So one could conclude that the broader market has become more cautious towards the stock.

The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers).


We consider it positive that insiders have made significant purchases in the last year. Even so, future earnings will be far more important to whether current shareholders make money. Before buying or selling a stock, we always recommend a close examination of historic growth trends, available here..

A Different Perspective

Syneos Health provided a TSR of 10.0% over the last twelve months. But that was short of the market average. On the bright side, that's still a gain, and it's actually better than the average return of 4.6% over half a decade This could indicate that the company is winning over new investors, as it pursues its strategy. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Like risks, for instance. Every company has them, and we've spotted 2 warning signs for Syneos Health (of which 1 shouldn't be ignored!) you should know about.

Syneos Health is not the only stock insiders are buying. So take a peek at this free list of growing companies with insider buying.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.